Home » Delay of Generic Wellbutrin XL Alleged in Class Action Motion
Delay of Generic Wellbutrin XL Alleged in Class Action Motion
January 5, 2010
Biovail and GlaxoSmithKline (GSK) have been accused of conspiring to delay generic competition for the antidepressant Wellbutrin XL in a motion filed by
an employee benefit plan seeking to certify a class action.